| Ytd | -67.29% | |
| 1y | -84.21% |
| Open | 1.04 | Prev Close | 1.04 | Low | 1.04 | High | 1.17 | Mkt Cap | 84.56K |
| Vol | 134.06K | Avg Vol | 2.58M | EPS | -116.81 | P/E | -0.01 | Forward P/E | -0.37 |
| Beta | 0.56 | Short Ratio | 0.02 | Inst. Own | 6.58% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 1.42 | 200-d Avg | 2.96 | 1yr Est | 12.00 |
PRFX News
First-Half 2026 and Recent Highlights:Raised $10 million through the Company's equity line facil
Interim CEO Efraim Cohen-Arazi Details $10 Million in New Capital, LayerBio's Preparations for the P
TEL AVIV, Israel, July 21, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or t
Battery-to-Revenue Intelligence is a new capability designed to extend the platform’s optimization w
New Capability Builds on Recently Completed Real-World Validation of DeepSolar Predict™ as the Solut
Validation Applied Utility-Scale Renewable Production, Weather and Market Data Across Day-Ahead and
Additional data reported by an independent research firm show comparable analgesic efficacy to ZYNRE
HITI rose sharply in pre-market trading on strong Q2 results and continued to rise after market open
PRF Technologies (NASDAQ: PRFX) stock falls sharply Monday morning. Read why analysts see this as a
Taylor Morrison Home soared 23.28% to $72.12 in pre-market trading after Berkshire Hathaway announce
Dell beats massive estimates, IBM launches $5B Project Lightwell, CrowdStrike expands cyber insuranc
Dell Technologies Inc. (DELL) stock rises 38.7% in premarket trading after strong fiscal Q1 sales an
Platform builds on NVIDIA Connect participation and previously announced weather-domain patent filin
Ropivacaine-only, NSAID-free formulation leverages a long-acting local anesthetic with a favorable s
Milestone supports advancement of PRF's drop-less ocular drug-delivery platform into next-stage U.S.
PainReform Ltd. (NASDAQ: PRFX - Get Free Report) was the target of a large decrease in short interes
LayerBio's OcuRing™-K program and broader ocular platform strengthen PRF's healthcare growth strateg
TEL AVIV, Israel, March 17, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or
Agreement Initiates Data-Driven Technical Due Diligence of an Operational, Utility-Scale Solar Asset
TEL AVIV, Israel, Feb. 11, 2026 (GLOBE NEWSWIRE) -- PRF Technologies (Nasdaq: PRFX) (“PRF” or the “C
Patent filing follows acceptance into the NVIDIA Connect Program Proprietary software targets weath
Penny stock PainReform Ltd. (NASDAQ: PRFX) stock climbed on Friday following the company's recent an
Shareholders Approved Name Change at January 6, 2026 Annual General Meeting as Company Evolves Beyon
TEL AVIV, Israel, Jan. 12, 2026 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), a clinical-stage
PainReform (NASDAQ: PRFX - Get Free Report) and Citius Pharmaceuticals (NASDAQ: CTXR - Get Free Repo
New lifecycle-wide audit platform provides complete data coverage, advanced diagnostics, and rapid t